Ernstoff Marc (21 results)

Hardcover. Condition: Fair. No Jacket. Readable copy. Pages may have considerable notes/highlighting. ~ ThriftBooks: Read More, Spend Less.

Hardcover. Condition: Very Good.

Softcover. Condition: As New. Leichte Kratzer / Abnutzungen / Druckstellen. The Society for Immunotherapy of Cancer's handbook, SITC's Guide to Managing Immunotherapy Toxicity, serves as a practical reference for managing side effects linked to FDA-approved cancer immunotherapy drugs. It is divided into two parts: Part I offers chapter-based overviews of immune checkpoint inhibitors, including anti-CTLA4 and anti-PD1/PD-L1 agents, along with approved combinations. These chapters detail mechanisms of action, indications, and toxicities encountered in early, advanced, and metastatic cancer patients. Part II focuses on common and uncommon toxicities affecting major organ sites. It begins with a general summary of management principles, followed by specific chapters on toxicities such as rash, mucosal irritation, joint and muscle toxicity, diarrhea, pneumonitis, endocrine, neurological, cardiac, renal, hematologic, and ocular toxicities. Each chapter provides guidance on assessing and treating these toxicities, with detailed summary tables for quick reference. Additionally, Part II addresses the management of special patient populations, including those with autoimmune diseases and geriatric patients, as well as treatment for fatigue and the financial impact of care. Written by leading experts in immuno-oncology, this text is an essential resource for clinical oncologists, emergency physicians, and other medical practitioners in both hospital and community settings, especially as immune checkpoint inh.

Condition: good. This book is in good condition, with minimal signs of wear and tear.

Condition: New.

Condition: New.

Condition: As New. Unread book in perfect condition.

Condition: New. pp. 270.

Paperback. Condition: Brand New. 1st edition. 255 pages. 9.00x7.50x0.75 inches. In Stock.

Paperback. Condition: Brand New. 1st pap/psc edition. 246 pages. 8.00x5.00x0.65 inches. In Stock.

Condition: New. pp. 270.

Condition: New. pp. 270.

Paperback / softback. Condition: New. New copy - Usually dispatched within 4 working days.

Condition: New. A practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Part One contains chapter-based overviews of immune checkpoint inhibitors in the clinic. Part Two is structured by common and uncommon toxicities that af.

Hardcover. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Taschenbuch. Condition: Neu. Immune Checkpoint Inhibitors in Cancer | Fumito Ito (u. a.) | Taschenbuch | Englisch | 2018 | Elsevier Health Sciences | EAN 9780323549486 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.

Taschenbuch. Condition: Neu. Neuware - The Society for Immunotherapy of Cancer's handbook,SITC's Guide to Managing Immunotherapy Toxicity, is a practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Separated into two parts, Part I contains chapter-based overviews of immune checkpoint inhibitors in the clinic, starting with anti-CTLA4 agents, anti-PD1/PD-L1 agents, and approved immunotherapeutic combinations. These chapters cover relevant mechanisms of action, indications, and toxicities seen while combating early, advanced, and metastatic stages in cancer patients. Part II is structured by common and uncommon toxicities that affect major organ sites throughout the body. It begins with a general summary of principles and management options followed by chapters focusing on specific toxicities such as rash and mucosal irritation, muscle and joint toxicity, diarrhea and colitis, pneumonitis, endocrine toxicities, neurological toxicities, cardiac toxicity, renal toxicity, hematologic toxicity, and ocular toxicities. Each chapter provides guidance on how to assess and treat the toxicity and how to support the patient through acute and chronic effects with detailed summary tables for quick reference. Part II concludes with chapters covering management of special patient populations, including patients with autoimmune disease and geriatric patients, treatment and management of fatigue, and a final chapter dedicated to cost effectiveness and the toll of financial toxicity on patients and caregivers.With chapters written by world-recognized leaders in the immuno-oncology field, this text provides thorough coverage of the toxicity and management of adverse effects for immune checkpoint inhibitors. It is an indispensable resource for clinical oncologists, emergency physicians, hospitalists and other medical practitioners in both the hospital and community clinic settings, especially as the use of immune checkpoint inhibitors becomes a fixture in oncology care.Key Features:- Outlines strategies for treating high-risk patients facing an acute or chronic side effect to immunotherapy- Provides numerous tables that condense and highlight pertinent information for quick reference- Describes the various clinical presentations and toxic reactions caused by immunotherapy- Purchase includes access to the Elektronisches Buch for use on most mobile devices or computer.

Paperback. Condition: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condition: new. Questo è un articolo print on demand.

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It's an ideal concise reference for trainee and practicing medical oncologists, as well as those in research. Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages. Helps you translate current research and literature into practical information for daily practice. Presents information logically organized by disease site. Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks. Consolidates today's available information on this timely topic into one convenient resource. 270 pp. Englisch.

Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It's an ideal concise reference for trainee and practicing medical oncologists, as well as those in research. Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages. Helps you translate current research and literature into practical information for daily practice. Presents information logically organized by disease site. Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks. Consolidates today's available information on this timely topic into one convenient resource.